Clinical trial
The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease
NCT05777616 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 15, 2021
- Completion date
- December 28, 2021
- Enrollment
- 166 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.